Back
#1
23.2%
Top 0.2%
23.2%
Top 2%
6.7%
Top 0.5%
5.8%
Top 62%
4.3%
Top 5%
4.0%
Top 0.5%
4.0%
Top 2%
2.0%
Top 2%
2.0%
Top 6%
1.6%
Top 2%
1.6%
Top 9%
1.6%
Top 2%
1.4%
Top 7%
1.4%
Top 49%
1.2%
Top 98%
1.0%
Top 8%
1.0%
Top 5%
1.0%
Top 3%
0.7%
Top 5%
0.7%
Top 53%
0.7%
Dopaminergic Medication Accentuates Fecal Gut Microbiome Changes in Parkinson's Disease
2022-12-26
neurology
Title + abstract only
View on medRxiv
Show abstract
Fecal gut microbiota changes are associated with Parkinsons disease (PD). However, disease related changes cannot readily be discerned from medication effects, as almost all participants in previous studies were using PD medication, and conclusive longitudinal data related to treatment initiation is lacking. Here, fecal gut microbiota composition was assessed in 62 de novo PD participants who were untreated at baseline and used PD medication at one-year follow-up, by means of 16S-sequencing. In ...
Predicted journal destinations
1
npj Parkinson's Disease
35 training papers
2
Movement Disorders
49 training papers
3
Brain
69 training papers
4
Annals of Neurology
43 training papers
5
Scientific Reports
701 training papers
6
Brain Communications
79 training papers
7
Parkinsonism & Related Disorders
16 training papers
8
Journal of Neurology, Neurosurgery & Psychiatry
26 training papers
9
Neurobiology of Aging
29 training papers
10
Neurology
38 training papers
11
Journal of Neurology
22 training papers
12
Frontiers in Neurology
74 training papers
13
Annals of Clinical and Translational Neurology
22 training papers
14
Alzheimer's & Dementia
84 training papers
15
Nature Communications
483 training papers
16
PLOS ONE
1737 training papers
17
eBioMedicine
82 training papers
18
European Journal of Neurology
20 training papers
19
Multiple Sclerosis Journal
15 training papers
20
Epilepsia
27 training papers
21
eLife
262 training papers